302 related articles for article (PubMed ID: 32588101)
21. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
Baschnagel AM; Tonlaar N; Eskandari M; Kumar T; Williams L; Hanna A; Pruetz BL; Wilson GD
J Oral Pathol Med; 2017 Mar; 46(3):208-213. PubMed ID: 27442811
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
Hendawy H; Esmail AD; Zahani AMN; Elmahdi AH; Ibrahiem A
J Immunoassay Immunochem; 2021 Nov; 42(6):571-595. PubMed ID: 33896397
[No Abstract] [Full Text] [Related]
23. CSC
Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
[TBL] [Abstract][Full Text] [Related]
24. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
26. In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
PLoS One; 2017; 12(10):e0186186. PubMed ID: 29028842
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis.
Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J
Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856
[TBL] [Abstract][Full Text] [Related]
29. High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.
Adnan Y; Ali SMA; Farooqui HA; Kayani HA; Idrees R; Awan MS
Int J Surg Oncol; 2022; 2022():9990489. PubMed ID: 35296132
[TBL] [Abstract][Full Text] [Related]
30. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
32. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
[TBL] [Abstract][Full Text] [Related]
33. A review of the racial heterogeneity of breast cancer stem cells.
Gyan E; Owiredu WKBA; Fondjo LA; Jackson AM; Green AR; Rahman GA
Gene; 2021 Sep; 796-797():145805. PubMed ID: 34197949
[TBL] [Abstract][Full Text] [Related]
34. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of ALDH1 and CD44 positivity for radiotherapy response and prognosis in early-stage glottic laryngeal squamous cell carcinoma.
Surmelioglu O; Erdogan K; Dagkiran M; Ozdemir S; Tarkan O; Uguz A
Pol J Pathol; 2022; 73(1):43-49. PubMed ID: 35848480
[TBL] [Abstract][Full Text] [Related]
36. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response.
Reid P; Marcu LG; Olver I; Moghaddasi L; Staudacher AH; Bezak E
Radiother Oncol; 2019 Jun; 135():1-12. PubMed ID: 31015153
[TBL] [Abstract][Full Text] [Related]
37. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
38. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
Sayed SI; Dwivedi RC; Katna R; Garg A; Pathak KA; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
Oral Oncol; 2011 Apr; 47(4):237-43. PubMed ID: 21382740
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
Han SA; Jang JH; Won KY; Lim SJ; Song JY
Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
[TBL] [Abstract][Full Text] [Related]
40. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]